[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Mol
J A C
JA
D002219:Carbamates / Q000627:therapeutic use*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D006760:Hospitalization; D006801:Humans; D020961:Lewy Body Disease / Q000188:drug therapy* / Q000523:psychology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D048448:Phenylcarbamates; D000068836:Rivastigmine; D013997:Time Factors; D016896:Treatment Outcome
D002219:Carbamates; D002800:Cholinesterase Inhibitors; D018696:Neuroprotective Agents; D048448:Phenylcarbamates; D000068836:Rivastigmine
Dementie met Lewy-lichaampjes; 2 patiënten met verergering door een atypisch antipsychoticum, maar met een gunstige reactie op de cholinesteraseremmer rivastigmine.